Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for larynx cancer

Purpose : Distinguishing persistent or recurrent tumor from postradiation edema, or soft tissue/cartilage necrosis in patients treated for carcinoma of the larynx can be difficult. Because recurrent tumor is often submucosal, multiple deep biopsies may be necessary before a diagnosis can be establis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International Journal of Radiation Oncology, Biology and Physics Biology and Physics, 1994-07, Vol.29 (4), p.841-845
Hauptverfasser: Greven, Kathryn M., Williams, Daniel W., Keyes, John W., McGuirt, W.Fred, Harkness, Beth A., Watson, Nat E., Raben, Milton, Frazier, Lisa C., Geisinger, Kim R., Cappellari, James O.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 845
container_issue 4
container_start_page 841
container_title International Journal of Radiation Oncology, Biology and Physics
container_volume 29
creator Greven, Kathryn M.
Williams, Daniel W.
Keyes, John W.
McGuirt, W.Fred
Harkness, Beth A.
Watson, Nat E.
Raben, Milton
Frazier, Lisa C.
Geisinger, Kim R.
Cappellari, James O.
description Purpose : Distinguishing persistent or recurrent tumor from postradiation edema, or soft tissue/cartilage necrosis in patients treated for carcinoma of the larynx can be difficult. Because recurrent tumor is often submucosal, multiple deep biopsies may be necessary before a diagnosis can be established. Positron emission tomography with 18F-2fluoro-2deoxyglucose (FDG) was studied for its ability to aid in this problem. Methods and Materials : Positron emission tomography (18FDG) scans were performed on 11 patients who were suspected of having persistent or recurrent tumor after radiation treatment for carcinoma of the larynx. Patients underwent thorough history and physical examinations, scans with computerized tomography, and pathologic evaluation when indicated. Standard uptake values were used to quantitate the FDG uptake in the larynx. Results : The time between completion of radiation treatment and positron emission tomography examination ranged from 2 to 26 months with a median of 6 months. Ten patients underwent computed tomography (CT) of the larynx, which revealed edema of the larynx (six patients), glottic mass (four patients), and cervical nodes (one patient). Positron emission tomography scans revealed increased FDG uptake in the larynx in five patients and laryngectomy confirmed the presence of carcinoma in these patients. Five patients had positron emission tomography results consistent with normal tissue changes in the larynx, and one patient had increased FDG uptake in neck nodes. This patient underwent laryngectomy, and no cancer was found in the primary site, but nodes were pathologically positive. One patient had slightly elevated FDG uptake and negative biopsy results. The remaining patients have been followed for 11 to 14 months since their positron emission studies and their examinations have remained stable. In patients without tumor, average standard uptake values of the larynx ranged from 2.4 to 4.7, and in patients with tumor, the range was 4.9 to 10.7. Conclusion : Positron emission tomography with labeled FDG appears to be useful in distinguishing benign from malignant changes in the larynx after radiation treatment. This noninvasive technique may be preferable to biopsy, which could traumatize radiation-damaged tissues and precipitate necrosis.
doi_str_mv 10.1016/0360-3016(94)90574-6
format Article
fullrecord <record><control><sourceid>proquest_osti_</sourceid><recordid>TN_cdi_proquest_miscellaneous_16946634</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0360301694905746</els_id><sourcerecordid>16946634</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-df0091ab01a607d4e4c910d7d9e92ac348c283150b4ca49ba8a74c8e4159553b3</originalsourceid><addsrcrecordid>eNp9kUFv1DAQhS0EKkvhH4DkA0JwCNix48QXJFSgIFXiAhI3y3EmXaPEDmOnpUf-OQ672mNPY3m-Gfu9R8hzzt5yxtU7JhSrRDm91vKNZk0rK_WA7HjX6ko0zc-HZHdCHpMnKf1ijHHeyjNy1jHJmKh35O9Hn7IP16tP-1JoXueIFMGtiBAc0BHjTD2iHbzNPgaa4PcKkwV66_OeLjH5jOUaZp_S1s9xjtdol_0d9YEuZQhCTjQj2AwDHcv6yeJd-EOdLQ_gU_JotFOCZ8d6Tn58_vT94kt19e3y68WHq8pJWedqGBnT3PaMW8XaQYJ0mrOhHTTo2johO1d3gjesl85K3dvOttJ1IHmjm0b04pzQw95YBJvkfAa3dzEEcNl0Suq6IK8OyIKxiEzZFFEOpskGiGsyXGmplJAFlAfQYUwJYTQL-rmoMpyZLRyzOW82542W5n84RpWxF8f9az_DcBo6plH6L499m5ydRiwG-XTCNilCNwV7f8Cg2HXjATc1W1iDx03MEP39__gH6ait6w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16946634</pqid></control><display><type>article</type><title>Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for larynx cancer</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Greven, Kathryn M. ; Williams, Daniel W. ; Keyes, John W. ; McGuirt, W.Fred ; Harkness, Beth A. ; Watson, Nat E. ; Raben, Milton ; Frazier, Lisa C. ; Geisinger, Kim R. ; Cappellari, James O.</creator><creatorcontrib>Greven, Kathryn M. ; Williams, Daniel W. ; Keyes, John W. ; McGuirt, W.Fred ; Harkness, Beth A. ; Watson, Nat E. ; Raben, Milton ; Frazier, Lisa C. ; Geisinger, Kim R. ; Cappellari, James O.</creatorcontrib><description>Purpose : Distinguishing persistent or recurrent tumor from postradiation edema, or soft tissue/cartilage necrosis in patients treated for carcinoma of the larynx can be difficult. Because recurrent tumor is often submucosal, multiple deep biopsies may be necessary before a diagnosis can be established. Positron emission tomography with 18F-2fluoro-2deoxyglucose (FDG) was studied for its ability to aid in this problem. Methods and Materials : Positron emission tomography (18FDG) scans were performed on 11 patients who were suspected of having persistent or recurrent tumor after radiation treatment for carcinoma of the larynx. Patients underwent thorough history and physical examinations, scans with computerized tomography, and pathologic evaluation when indicated. Standard uptake values were used to quantitate the FDG uptake in the larynx. Results : The time between completion of radiation treatment and positron emission tomography examination ranged from 2 to 26 months with a median of 6 months. Ten patients underwent computed tomography (CT) of the larynx, which revealed edema of the larynx (six patients), glottic mass (four patients), and cervical nodes (one patient). Positron emission tomography scans revealed increased FDG uptake in the larynx in five patients and laryngectomy confirmed the presence of carcinoma in these patients. Five patients had positron emission tomography results consistent with normal tissue changes in the larynx, and one patient had increased FDG uptake in neck nodes. This patient underwent laryngectomy, and no cancer was found in the primary site, but nodes were pathologically positive. One patient had slightly elevated FDG uptake and negative biopsy results. The remaining patients have been followed for 11 to 14 months since their positron emission studies and their examinations have remained stable. In patients without tumor, average standard uptake values of the larynx ranged from 2.4 to 4.7, and in patients with tumor, the range was 4.9 to 10.7. Conclusion : Positron emission tomography with labeled FDG appears to be useful in distinguishing benign from malignant changes in the larynx after radiation treatment. This noninvasive technique may be preferable to biopsy, which could traumatize radiation-damaged tissues and precipitate necrosis.</description><identifier>ISSN: 0360-3016</identifier><identifier>EISSN: 1879-355X</identifier><identifier>DOI: 10.1016/0360-3016(94)90574-6</identifier><identifier>PMID: 8040032</identifier><identifier>CODEN: IOBPD3</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Biological and medical sciences ; BIOLOGY AND MEDICINE, APPLIED STUDIES ; Deoxyglucose - analogs &amp; derivatives ; Deoxyglucose - pharmacokinetics ; DIAGNOSIS ; Diagnosis, Differential ; Edema - diagnosis ; Edema - etiology ; Ent. Stomatology ; Fluorine radioisotope ; Fluorine Radioisotopes ; Fluorodeoxyglucose F18 ; Humans ; Investigative techniques, diagnostic techniques (general aspects) ; Laryngeal Neoplasms - diagnostic imaging ; Laryngeal Neoplasms - metabolism ; Laryngeal Neoplasms - radiotherapy ; Laryngectomy ; LARYNX ; Larynx - diagnostic imaging ; Larynx - metabolism ; Larynx - surgery ; local ; Medical sciences ; Necrosis ; Neoplasm recurrence ; Neoplasm Recurrence, Local - diagnosis ; Neoplasm Recurrence, Local - diagnostic imaging ; Neoplasm Recurrence, Local - metabolism ; NEOPLASMS ; Positron emission tomography ; Radiation injuries ; Radiation Injuries - diagnosis ; Radiation Injuries - diagnostic imaging ; Radiation Injuries - metabolism ; Radionuclide investigations ; RADIOTHERAPY ; Radiotherapy - adverse effects ; SIDE EFFECTS ; Tomography, Emission-Computed</subject><ispartof>International Journal of Radiation Oncology, Biology and Physics, 1994-07, Vol.29 (4), p.841-845</ispartof><rights>1994</rights><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-df0091ab01a607d4e4c910d7d9e92ac348c283150b4ca49ba8a74c8e4159553b3</citedby><cites>FETCH-LOGICAL-c442t-df0091ab01a607d4e4c910d7d9e92ac348c283150b4ca49ba8a74c8e4159553b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/0360301694905746$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4159395$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8040032$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/86492$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>Greven, Kathryn M.</creatorcontrib><creatorcontrib>Williams, Daniel W.</creatorcontrib><creatorcontrib>Keyes, John W.</creatorcontrib><creatorcontrib>McGuirt, W.Fred</creatorcontrib><creatorcontrib>Harkness, Beth A.</creatorcontrib><creatorcontrib>Watson, Nat E.</creatorcontrib><creatorcontrib>Raben, Milton</creatorcontrib><creatorcontrib>Frazier, Lisa C.</creatorcontrib><creatorcontrib>Geisinger, Kim R.</creatorcontrib><creatorcontrib>Cappellari, James O.</creatorcontrib><title>Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for larynx cancer</title><title>International Journal of Radiation Oncology, Biology and Physics</title><addtitle>Int J Radiat Oncol Biol Phys</addtitle><description>Purpose : Distinguishing persistent or recurrent tumor from postradiation edema, or soft tissue/cartilage necrosis in patients treated for carcinoma of the larynx can be difficult. Because recurrent tumor is often submucosal, multiple deep biopsies may be necessary before a diagnosis can be established. Positron emission tomography with 18F-2fluoro-2deoxyglucose (FDG) was studied for its ability to aid in this problem. Methods and Materials : Positron emission tomography (18FDG) scans were performed on 11 patients who were suspected of having persistent or recurrent tumor after radiation treatment for carcinoma of the larynx. Patients underwent thorough history and physical examinations, scans with computerized tomography, and pathologic evaluation when indicated. Standard uptake values were used to quantitate the FDG uptake in the larynx. Results : The time between completion of radiation treatment and positron emission tomography examination ranged from 2 to 26 months with a median of 6 months. Ten patients underwent computed tomography (CT) of the larynx, which revealed edema of the larynx (six patients), glottic mass (four patients), and cervical nodes (one patient). Positron emission tomography scans revealed increased FDG uptake in the larynx in five patients and laryngectomy confirmed the presence of carcinoma in these patients. Five patients had positron emission tomography results consistent with normal tissue changes in the larynx, and one patient had increased FDG uptake in neck nodes. This patient underwent laryngectomy, and no cancer was found in the primary site, but nodes were pathologically positive. One patient had slightly elevated FDG uptake and negative biopsy results. The remaining patients have been followed for 11 to 14 months since their positron emission studies and their examinations have remained stable. In patients without tumor, average standard uptake values of the larynx ranged from 2.4 to 4.7, and in patients with tumor, the range was 4.9 to 10.7. Conclusion : Positron emission tomography with labeled FDG appears to be useful in distinguishing benign from malignant changes in the larynx after radiation treatment. This noninvasive technique may be preferable to biopsy, which could traumatize radiation-damaged tissues and precipitate necrosis.</description><subject>Biological and medical sciences</subject><subject>BIOLOGY AND MEDICINE, APPLIED STUDIES</subject><subject>Deoxyglucose - analogs &amp; derivatives</subject><subject>Deoxyglucose - pharmacokinetics</subject><subject>DIAGNOSIS</subject><subject>Diagnosis, Differential</subject><subject>Edema - diagnosis</subject><subject>Edema - etiology</subject><subject>Ent. Stomatology</subject><subject>Fluorine radioisotope</subject><subject>Fluorine Radioisotopes</subject><subject>Fluorodeoxyglucose F18</subject><subject>Humans</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Laryngeal Neoplasms - diagnostic imaging</subject><subject>Laryngeal Neoplasms - metabolism</subject><subject>Laryngeal Neoplasms - radiotherapy</subject><subject>Laryngectomy</subject><subject>LARYNX</subject><subject>Larynx - diagnostic imaging</subject><subject>Larynx - metabolism</subject><subject>Larynx - surgery</subject><subject>local</subject><subject>Medical sciences</subject><subject>Necrosis</subject><subject>Neoplasm recurrence</subject><subject>Neoplasm Recurrence, Local - diagnosis</subject><subject>Neoplasm Recurrence, Local - diagnostic imaging</subject><subject>Neoplasm Recurrence, Local - metabolism</subject><subject>NEOPLASMS</subject><subject>Positron emission tomography</subject><subject>Radiation injuries</subject><subject>Radiation Injuries - diagnosis</subject><subject>Radiation Injuries - diagnostic imaging</subject><subject>Radiation Injuries - metabolism</subject><subject>Radionuclide investigations</subject><subject>RADIOTHERAPY</subject><subject>Radiotherapy - adverse effects</subject><subject>SIDE EFFECTS</subject><subject>Tomography, Emission-Computed</subject><issn>0360-3016</issn><issn>1879-355X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUFv1DAQhS0EKkvhH4DkA0JwCNix48QXJFSgIFXiAhI3y3EmXaPEDmOnpUf-OQ672mNPY3m-Gfu9R8hzzt5yxtU7JhSrRDm91vKNZk0rK_WA7HjX6ko0zc-HZHdCHpMnKf1ijHHeyjNy1jHJmKh35O9Hn7IP16tP-1JoXueIFMGtiBAc0BHjTD2iHbzNPgaa4PcKkwV66_OeLjH5jOUaZp_S1s9xjtdol_0d9YEuZQhCTjQj2AwDHcv6yeJd-EOdLQ_gU_JotFOCZ8d6Tn58_vT94kt19e3y68WHq8pJWedqGBnT3PaMW8XaQYJ0mrOhHTTo2johO1d3gjesl85K3dvOttJ1IHmjm0b04pzQw95YBJvkfAa3dzEEcNl0Suq6IK8OyIKxiEzZFFEOpskGiGsyXGmplJAFlAfQYUwJYTQL-rmoMpyZLRyzOW82542W5n84RpWxF8f9az_DcBo6plH6L499m5ydRiwG-XTCNilCNwV7f8Cg2HXjATc1W1iDx03MEP39__gH6ait6w</recordid><startdate>19940701</startdate><enddate>19940701</enddate><creator>Greven, Kathryn M.</creator><creator>Williams, Daniel W.</creator><creator>Keyes, John W.</creator><creator>McGuirt, W.Fred</creator><creator>Harkness, Beth A.</creator><creator>Watson, Nat E.</creator><creator>Raben, Milton</creator><creator>Frazier, Lisa C.</creator><creator>Geisinger, Kim R.</creator><creator>Cappellari, James O.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope><scope>OTOTI</scope></search><sort><creationdate>19940701</creationdate><title>Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for larynx cancer</title><author>Greven, Kathryn M. ; Williams, Daniel W. ; Keyes, John W. ; McGuirt, W.Fred ; Harkness, Beth A. ; Watson, Nat E. ; Raben, Milton ; Frazier, Lisa C. ; Geisinger, Kim R. ; Cappellari, James O.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-df0091ab01a607d4e4c910d7d9e92ac348c283150b4ca49ba8a74c8e4159553b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Biological and medical sciences</topic><topic>BIOLOGY AND MEDICINE, APPLIED STUDIES</topic><topic>Deoxyglucose - analogs &amp; derivatives</topic><topic>Deoxyglucose - pharmacokinetics</topic><topic>DIAGNOSIS</topic><topic>Diagnosis, Differential</topic><topic>Edema - diagnosis</topic><topic>Edema - etiology</topic><topic>Ent. Stomatology</topic><topic>Fluorine radioisotope</topic><topic>Fluorine Radioisotopes</topic><topic>Fluorodeoxyglucose F18</topic><topic>Humans</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Laryngeal Neoplasms - diagnostic imaging</topic><topic>Laryngeal Neoplasms - metabolism</topic><topic>Laryngeal Neoplasms - radiotherapy</topic><topic>Laryngectomy</topic><topic>LARYNX</topic><topic>Larynx - diagnostic imaging</topic><topic>Larynx - metabolism</topic><topic>Larynx - surgery</topic><topic>local</topic><topic>Medical sciences</topic><topic>Necrosis</topic><topic>Neoplasm recurrence</topic><topic>Neoplasm Recurrence, Local - diagnosis</topic><topic>Neoplasm Recurrence, Local - diagnostic imaging</topic><topic>Neoplasm Recurrence, Local - metabolism</topic><topic>NEOPLASMS</topic><topic>Positron emission tomography</topic><topic>Radiation injuries</topic><topic>Radiation Injuries - diagnosis</topic><topic>Radiation Injuries - diagnostic imaging</topic><topic>Radiation Injuries - metabolism</topic><topic>Radionuclide investigations</topic><topic>RADIOTHERAPY</topic><topic>Radiotherapy - adverse effects</topic><topic>SIDE EFFECTS</topic><topic>Tomography, Emission-Computed</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Greven, Kathryn M.</creatorcontrib><creatorcontrib>Williams, Daniel W.</creatorcontrib><creatorcontrib>Keyes, John W.</creatorcontrib><creatorcontrib>McGuirt, W.Fred</creatorcontrib><creatorcontrib>Harkness, Beth A.</creatorcontrib><creatorcontrib>Watson, Nat E.</creatorcontrib><creatorcontrib>Raben, Milton</creatorcontrib><creatorcontrib>Frazier, Lisa C.</creatorcontrib><creatorcontrib>Geisinger, Kim R.</creatorcontrib><creatorcontrib>Cappellari, James O.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>OSTI.GOV</collection><jtitle>International Journal of Radiation Oncology, Biology and Physics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Greven, Kathryn M.</au><au>Williams, Daniel W.</au><au>Keyes, John W.</au><au>McGuirt, W.Fred</au><au>Harkness, Beth A.</au><au>Watson, Nat E.</au><au>Raben, Milton</au><au>Frazier, Lisa C.</au><au>Geisinger, Kim R.</au><au>Cappellari, James O.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for larynx cancer</atitle><jtitle>International Journal of Radiation Oncology, Biology and Physics</jtitle><addtitle>Int J Radiat Oncol Biol Phys</addtitle><date>1994-07-01</date><risdate>1994</risdate><volume>29</volume><issue>4</issue><spage>841</spage><epage>845</epage><pages>841-845</pages><issn>0360-3016</issn><eissn>1879-355X</eissn><coden>IOBPD3</coden><abstract>Purpose : Distinguishing persistent or recurrent tumor from postradiation edema, or soft tissue/cartilage necrosis in patients treated for carcinoma of the larynx can be difficult. Because recurrent tumor is often submucosal, multiple deep biopsies may be necessary before a diagnosis can be established. Positron emission tomography with 18F-2fluoro-2deoxyglucose (FDG) was studied for its ability to aid in this problem. Methods and Materials : Positron emission tomography (18FDG) scans were performed on 11 patients who were suspected of having persistent or recurrent tumor after radiation treatment for carcinoma of the larynx. Patients underwent thorough history and physical examinations, scans with computerized tomography, and pathologic evaluation when indicated. Standard uptake values were used to quantitate the FDG uptake in the larynx. Results : The time between completion of radiation treatment and positron emission tomography examination ranged from 2 to 26 months with a median of 6 months. Ten patients underwent computed tomography (CT) of the larynx, which revealed edema of the larynx (six patients), glottic mass (four patients), and cervical nodes (one patient). Positron emission tomography scans revealed increased FDG uptake in the larynx in five patients and laryngectomy confirmed the presence of carcinoma in these patients. Five patients had positron emission tomography results consistent with normal tissue changes in the larynx, and one patient had increased FDG uptake in neck nodes. This patient underwent laryngectomy, and no cancer was found in the primary site, but nodes were pathologically positive. One patient had slightly elevated FDG uptake and negative biopsy results. The remaining patients have been followed for 11 to 14 months since their positron emission studies and their examinations have remained stable. In patients without tumor, average standard uptake values of the larynx ranged from 2.4 to 4.7, and in patients with tumor, the range was 4.9 to 10.7. Conclusion : Positron emission tomography with labeled FDG appears to be useful in distinguishing benign from malignant changes in the larynx after radiation treatment. This noninvasive technique may be preferable to biopsy, which could traumatize radiation-damaged tissues and precipitate necrosis.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>8040032</pmid><doi>10.1016/0360-3016(94)90574-6</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0360-3016
ispartof International Journal of Radiation Oncology, Biology and Physics, 1994-07, Vol.29 (4), p.841-845
issn 0360-3016
1879-355X
language eng
recordid cdi_proquest_miscellaneous_16946634
source MEDLINE; Elsevier ScienceDirect Journals
subjects Biological and medical sciences
BIOLOGY AND MEDICINE, APPLIED STUDIES
Deoxyglucose - analogs & derivatives
Deoxyglucose - pharmacokinetics
DIAGNOSIS
Diagnosis, Differential
Edema - diagnosis
Edema - etiology
Ent. Stomatology
Fluorine radioisotope
Fluorine Radioisotopes
Fluorodeoxyglucose F18
Humans
Investigative techniques, diagnostic techniques (general aspects)
Laryngeal Neoplasms - diagnostic imaging
Laryngeal Neoplasms - metabolism
Laryngeal Neoplasms - radiotherapy
Laryngectomy
LARYNX
Larynx - diagnostic imaging
Larynx - metabolism
Larynx - surgery
local
Medical sciences
Necrosis
Neoplasm recurrence
Neoplasm Recurrence, Local - diagnosis
Neoplasm Recurrence, Local - diagnostic imaging
Neoplasm Recurrence, Local - metabolism
NEOPLASMS
Positron emission tomography
Radiation injuries
Radiation Injuries - diagnosis
Radiation Injuries - diagnostic imaging
Radiation Injuries - metabolism
Radionuclide investigations
RADIOTHERAPY
Radiotherapy - adverse effects
SIDE EFFECTS
Tomography, Emission-Computed
title Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for larynx cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T07%3A20%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_osti_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Distinguishing%20tumor%20recurrence%20from%20irradiation%20sequelae%20with%20positron%20emission%20tomography%20in%20patients%20treated%20for%20larynx%20cancer&rft.jtitle=International%20Journal%20of%20Radiation%20Oncology,%20Biology%20and%20Physics&rft.au=Greven,%20Kathryn%20M.&rft.date=1994-07-01&rft.volume=29&rft.issue=4&rft.spage=841&rft.epage=845&rft.pages=841-845&rft.issn=0360-3016&rft.eissn=1879-355X&rft.coden=IOBPD3&rft_id=info:doi/10.1016/0360-3016(94)90574-6&rft_dat=%3Cproquest_osti_%3E16946634%3C/proquest_osti_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16946634&rft_id=info:pmid/8040032&rft_els_id=0360301694905746&rfr_iscdi=true